Catalyst
Slingshot members are tracking this event:
European Commission Grants Marketing Authorization for Teva’s CINQAERO (reslizumab)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TEVA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 18, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Comission, Marketing Authorization, Cinqaero, Reslizumab
